The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
LRRK2 in Parkinson's disease: protein domains and functional insights
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
MOLMOL: A program for display and analysis of macromolecular structures
Koradi, R., Billeter, M., & Wüthrich, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00009-4 · Cited by 7,163
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Self-citationCloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
The leucine-rich repeat as a protein recognition motif
Kobe, B. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(01)00266-4 · Cited by 1,679
Detecting Protein Function and Protein-Protein Interactions from Genome Sequences
Marcotte, E. M., Pellegrini, M., Ng, H.-L., Rice, D. W., Yeates, T. O., & Eisenberg, D. (1999) · Science · doi:10.1126/science.285.5428.751 · Cited by 1,670
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
The RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,228
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Nolen, B., Taylor, S., & Ghosh, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.024 · Cited by 1,167
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
The ankyrin repeat as molecular architecture for protein recognition
Mosavi, L. K., Cammett, T. J., Desrosiers, D. C., & Peng, Z. (2004) · Protein Science · doi:10.1110/ps.03554604 · Cited by 907
Stenmark, H., & Olkkonen, V. M. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reviews3007 · Cited by 879
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication
Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F. B., Mendenhall, M. D., Sicheri, F., Pawson, T., & Tyers, M. (2001) · Nature · doi:10.1038/35107009 · Cited by 759
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., & Goldsmith, E. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80351-7 · Cited by 729
3D-Jury: a simple approach to improve protein structure predictions
Ginalski, K., Elofsson, A., Fischer, D., & Rychlewski, L. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg124 · Cited by 719
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Protein Repeats: Structures, Functions, and Evolution
Andrade, M. A., Perez-Iratxeta, C., & Ponting, C. P. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2001.4392 · Cited by 615
FFAS03: a server for profile-profile sequence alignments
Jaroszewski, L., Rychlewski, L., Li, Z., Li, W., & Godzik, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki418 · Cited by 594
Mixed-lineage kinase control of JNK and p38 MAPK pathways
Gallo, K. A., & Johnson, G. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm906 · Cited by 572
Self-citationTing, A. T., Pimentel‐Muiños, F. X., & Seed, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01007.x · Cited by 550
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
Self-citationA frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., et al. (2000) · PubMed · Cited by 528
Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998) · Nature · doi:10.1038/26155 · Cited by 524
Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martínez‐Lage, J. M., Trenkwalder, C., et al. (2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 514
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508052102 · Cited by 424
Ardley, H. C., & Robinson, P. A. (2005) · Essays in Biochemistry · doi:10.1042/bse0410015 · Cited by 390
The RIP kinases: crucial integrators of cellular stress
Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 382
GEFs: structural basis for their activation of small GTP-binding proteins
Cherfils, J., & Chardin, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01429-2 · Cited by 341
Roc, a Ras/GTPase domain in complex proteins
Bosgraaf, L., & Van Haastert, P. J. M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.008 · Cited by 320
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
Ross, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20731 · Cited by 268
Self-citationAn LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*
Berg, D., Schweitzer, K. J., Leitner, P., Zimprich, A., Lichtner, P., Belcredi, P., Brüssel, T., Schulte, C., Maass, S., Nägele, T., et al. (2005) · Brain · doi:10.1093/brain/awh666 · Cited by 261
Lrrk2 pathogenic substitutions in Parkinson's disease
Mata, I. F., Kachergus, J. M., Taylor, J. P., Lincoln, S., Aasly, J., Lynch, T., Hulihan, M. M., Cobb, S. A., Wu, R.-M., Lu, C.-S., et al. (2005) · Neurogenetics · doi:10.1007/s10048-005-0005-1 · Cited by 231
Self-citationSchwartz, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01582 · Cited by 194
Clinical features of LRRK2‐associated Parkinson's disease in central Norway
Aasly, J. O., Toft, M., Fernandez‐Mata, I., Kachergus, J., Hulihan, M., White, L. R., & Farrer, M. (2005) · Annals of Neurology · doi:10.1002/ana.20456 · Cited by 191
Self-citationUntying the regulation of the Raf-1 kinase
Dhillon, A. S., & Kolch, W. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00244-8 · Cited by 180
LRRK2 gene in Parkinson disease: Mutation analysis and case control association study
Paisán-Ruíz, C., Lang, A. E., Kawarai, T., Sato, C., Salehi-Rad, S., Fisman, G. K., Al-Khairallah, T., St George-Hyslop, P., Singleton, A., & Rogaeva, E. (2005) · Neurology · doi:10.1212/01.wnl.0000167552.79769.b3 · Cited by 178
LRRK2 mutations in Parkinson disease
Farrer, M. J., Stone, J., Mata, I. F., Lincoln, S. J., Kachergus, J. M., Hulihan, M., Strain, K. J., & Maraganore, D. M. (2005) · Neurology · doi:10.1212/01.wnl.0000169023.51764.b0 · Cited by 153
Self-citationA clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
Zabetian, C. P., Samii, A., Mosley, A. D., Roberts, J. W., Leis, B. C., Yearout, D., Raskind, W. H., & Griffith, A. (2005) · Neurology · doi:10.1212/01.wnl.0000172630.22804.73 · Cited by 150
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 144
Lesage, S., Leutenegger, A., Ibáñez, P., Janin, S., Lohmann, E., Dürr, A., & Brice, A. (2005) · The American Journal of Human Genetics · doi:10.1086/432422 · Cited by 135
Anatomical localization of leucine-rich repeat kinase 2 in mouse brain
Melrose, H. L., Lincoln, S. J., Tyndall, G., Dickson, D. W., & Farrer, M. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.017 · Cited by 132
Self-citationLeung, I., & Lassam, N. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32408 · Cited by 131
Ubiquitin, proteasome and parkin
Tanaka, K., Suzuki, T., Hattori, N., & Mizuno, Y. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.026 · Cited by 123
Johnson, G. L., Dohlman, H. G., & Graves, L. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.004 · Cited by 119
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
Korr, D., Toschi, L., Donner, P., Pohlenz, H., Kreft, B., & Weiss, B. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.015 · Cited by 115
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Taylor, J. P., Mata, I. F., & Farrer, M. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.004 · Cited by 108
Self-citationStructure and stability of the ankyrin domain of the Drosophila Notch receptor
Zweifel, M. E., Leahy, D. J., Hughson, F. M., & Barrick, D. (2003) · Protein Science · doi:10.1110/ps.03279003 · Cited by 99
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Self-citationParkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics
Kay, D. M., Zabetian, C. P., Factor, S. A., Nutt, J. G., Samii, A., Griffith, A., Bird, T. D., Kramer, P., Higgins, D. S., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20751 · Cited by 89
Thirty‐plus functional families from a single motif
Yu, L., Smith, T. F., & Gaitatzes, C. G. (2000) · Protein Science · doi:10.1110/ps.9.12.2470 · Cited by 88
Yaffe, M. B., & Smerdon, S. J. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.133346 · Cited by 83
Function of the Rho Family GTPases in Ras-stimulated Raf Activation
Li, W., Kopera, H. C., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103496200 · Cited by 78
Lu, C.-S., Simons, E. J., Wu‐Chou, Y., et al. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.003 · Cited by 78
LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain
Simón‐Sánchez, J., Herranz‐Pérez, V., Olucha‐Bordonau, F., & Pérez‐Tur, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04616.x · Cited by 77
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
Kay, D. M., Kramer, P., Higgins, D. S., Zabetian, C. P., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20618 · Cited by 76
Ruas, M., Brookes, S., McDonald, N. Q., & Peters, G. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202918 · Cited by 76
Analysis of LRRK2 functional domains in nondominant Parkinson disease
Skipper, L. M., Shen, H., Chua, E., Bonnard, C., Kolatkar, P. R., Tan, L. C. S., Jamora, R. D. G., Puvan, K., Puong, K. Y., Zhao, Y., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180517.70572.37 · Cited by 75
Self-citationCdc42 Induces Activation Loop Phosphorylation and Membrane Targeting of Mixed Lineage Kinase 3
Du, Y., Böck, B. C., Schachter, K. A., Chao, M., & Gallo, K. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502671200 · Cited by 74
Self-citationWszołek, Z. K., Vieregge, P., Uitti, R. J., Gasser, T., Yasuhara, O., McGeer, P. L., Berry, K., Calne, D. B., Vingerhoets, F. J. G., Klein, C., et al. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)00013-8 · Cited by 74
Interaction of G?? with RACK1 and other WD40 repeat proteins*1
Chen, S. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.019 · Cited by 68
Structural Fingerprints of the Ras-GTPase Activating Proteins Neurofibromin and p120GAP
Ahmadian, M. R., Kiel, C., Stege, P., & Scheffzek, K. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00514-x · Cited by 61
LRRK2 mutations and Parkinsonism
Albrecht, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74810-8 · Cited by 56
Vacratsis, P. O., & Gallo, K. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002858200 · Cited by 55
Self-citationLRRK2 mutations and Parkinsonism
Toft, M., Mata, I. F., Kachergus, J. M., Ross, O. A., & Farrer, M. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74809-1 · Cited by 31
Self-citation
Cited by
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
New insights into the function and regulation of mitochondrial fission
Otera, H., Ishihara, N., & Mihara, K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.002 · Cited by 479
Metadata
- Authors
- Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P., & Gallo, K. A.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 29
- Issue
- 5
- Pages
- 286-293
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2031345305
- Cited by
- 489
- References
- 80
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.